Key facts
- This page summarizes Steven A. J. Salamon's Form 4 filing for DELCATH SYSTEMS, INC. (DCTH).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 01 Nov 2024, 15:20.
Steven A. J. Salamon - 30 Oct 2024 Form 4 Insider Report for DELCATH SYSTEMS, INC. (DCTH)
- Reporting relationship
- Director
- Issuer ticker
- DCTH
- Reported as of
- 30 Oct 2024
- Net transaction value
- +$500,000
- SEC form
- 4
- Accepted by SEC
- 01 Nov 2024, 15:20:34 UTC
- Prior SEC filing
- 28 May 2024
- Next SEC filing
- 27 Dec 2024
- Source filing
- View source filing
- Reporting owner signature
- Steven Salamon
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Steven A. J. Salamon filed Form 4 for DELCATH SYSTEMS, INC. (DCTH) on 01 Nov 2024.
Change
- Previous filing in this sequence was filed on 28 May 2024.
- Current net transaction value: +$500,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DCTH
transaction
Derivative
Tranche B warrants to purchase F-4 Preferred Stock
Options Exercise
- Transaction value
- $500,000
- Shares
- +500
- Change %
- Price
- $1000.00
- Shares after
- 0
- Date
- 30 Oct 2024
- Ownership
- By Rosalind Advisors, Inc., the advisor to the Rosalind Funds
- Underlying class
- F-4 PREFERRED STOCK
- Underlying amount
- 500
- Exercise price
- $1000.00
- Footnotes
- F1, F2, F3
DCTH
transaction
Derivative
8% CONVERTIBLE NOTE
Expiration (or cancellation) of long derivative position with value received
- Transaction value
- $0
- Shares
- 0
- Change %
- Price
- $0.000000
- Shares after
- 0
- Date
- 30 Oct 2024
- Ownership
- By Rosalind Advisors, Inc., the advisor to the Rosalind Funds
- Underlying class
- CASH
- Underlying amount
- $1,423,333
- Exercise price
- $0.000000
- Footnotes
- F3, F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Immediately exercisable
Footnote F2
The Tranche B Warrants expire the earlier of (i) twenty-one (21) days following the date of the Issuer's public announcement of record at least $10,000,000 in quarterly U.S. revenue from the commercialization of HEPZATO and (ii) March 31, 2026. The Issuer announced on October 17, 2024 that it had recorded at least $10,000,000 in quarterly U.S. revenue from the commercialization of HEPZATO and therefore such Tranche B Warrants expire on November 7, 2024.
Footnote F3
Reporting Persons disclaims beneficial ownership over the shares except to the extent of his or its respective pecuniary interest therein
Footnote F4
N/A
Footnote F5
Delcath repaid the DELCATH SYSTEM - 8% CONVERTIBLE NOTE in full with cash of $1,423,333.